Metraipolis › archive › dc_cd80d364c5e4

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42732142
DOI
10.12688/wellcomeopenres.26466.2
License (as archived)
solo-consultazione
Archived
2026-10-16T16:35:09.706Z
SHA-256 of the archived text
93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f
Stable URL of this page
https://metraipolis.com/documento/dc_cd80d364c5e4

How to cite

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142 — Europe PMC (en), https://europepmc.org/article/MED/42732142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd80d364c5e4 (Metraipolis archive dc_cd80d364c5e4, sha256 93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f)
BibTeX
@misc{dccd80d364c5e4,
  title = {What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An… — Europe PMC PMID:42732142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42732142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd80d364c5e4; sha256 93241bff2f4467686a4be2ed8cc663badf50f5d0c4b194b24eda00237b948c1f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42732142. Agents can read the archived copy with the MCP tool read_document.